<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="case-report" dtd-version="1.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JRD</journal-id>
<journal-title-group>
<journal-title>Journal of Rheumatic Diseases</journal-title>
<abbrev-journal-title>J Rheum Dis</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">2093-940X</issn>
<issn pub-type="epub">2233-4718</issn>
<publisher>
<publisher-name>The Korean College of Rheumatology</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.4078/jrd.2013.20.5.319</article-id>
<article-id pub-id-type="publisher-id">jrd-20-319</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Case of Sj&#x00F6;gren&#x0027;s Syndrome Associated with Neuromyelitis Optica</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en">
<surname>Kim</surname><given-names>Kyung Han</given-names></name>
<xref ref-type="aff" rid="aff1-jrd-20-319"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en">
<surname>Park</surname><given-names>Su-Min</given-names></name>
<xref ref-type="aff" rid="aff1-jrd-20-319"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en">
<surname>Kim</surname><given-names>Bo-sung</given-names></name>
<xref ref-type="aff" rid="aff1-jrd-20-319"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en">
<surname>Han</surname><given-names>Seung Hee</given-names></name>
<xref ref-type="aff" rid="aff1-jrd-20-319"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en">
<surname>Lee</surname><given-names>Sang Yeob</given-names></name>
<xref ref-type="aff" rid="aff1-jrd-20-319"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en">
<surname>Chung</surname><given-names>Won Tae</given-names></name>
<xref ref-type="aff" rid="aff1-jrd-20-319"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en">
<surname>Lee</surname><given-names>Sung Won</given-names></name>
<xref ref-type="corresp" rid="c1-jrd-20-319"/>
<xref ref-type="aff" rid="aff1-jrd-20-319"/>
</contrib>
<aff id="aff1-jrd-20-319" xml:lang="en">Division of Rheumatology, Department of Internal Medicine, College of Medicine, Dong-A University, Busan, <country>Korea</country></aff>
</contrib-group>
<author-notes>
<corresp id="c1-jrd-20-319">Corresponding to : Sung Won Lee, Division of Rheumatology, Department of Internal Medicine, College of Medicine, Dong-A University, 1, Dongdaesin-dong 3-ga, Seo-gu, Busan 602-715, Korea. E-mail : <email>leesw@dau.ac.kr</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>10</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>10</month>
<year>2013</year>
</pub-date>
<volume>20</volume>
<issue>5</issue>
<fpage>319</fpage>
<lpage>322</lpage>
<history>
<date date-type="received"><day>13</day><month>08</month><year>2012</year></date>
<date date-type="revised"><day>11</day><month>10</month><year>2012</year></date>
<date date-type="accepted"><day>15</day><month>10</month><year>2012</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2013 The Korean College of Rheumatology</copyright-statement>
<copyright-year>2013</copyright-year>
<license><license-p>This is a Free Access article, which permits unrestricted non-commerical use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license>
</permissions>
<abstract xml:lang="en">
<title>Abstract</title>
<p>Neuromyelitis optica (NMO) is an idiopathic inflammatory demyelinating disease, characterized by optic neuritis and myelitis. NMO is a very uncommon and serious neurologic manifestation of Sj&#x00F6;gren&#x0027;s syndrome. We report on a 32-year-old female with NMO as central nerve system involvement of Sj&#x00F6;gren&#x0027;s syndrome. She had a transverse myelitis ten years ago and did not have symptoms for a long period of time. She visited the emergency center because of worsening weakness of both limbs. She had an appendectomy three days ago before hospitalization. Cervical spinal magnetic resonance imaging showed increased signal intensity in T2-weighted images from the cervical (C2) to the upper thoracic (T4) spinal cord. As serum NMO-IgG was positive, we diagnosed neuromyelitis optica and treated with high dose steroid, but failed. Therefore, we treated with plasmapheresis and the patient was discharged without any neurological deficits.</p>
</abstract>
<kwd-group xml:lang="en">
<kwd>Sj&#x00F6;gren&#x0027;s syndrome</kwd>
<kwd>Neuromyelitis optica</kwd>
</kwd-group>
</article-meta>
</front>
<back>
<ref-list>
<title>References</title>
<ref id="b1-jrd-20-319"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname> <given-names>EL</given-names></name> <name><surname>Provost</surname> <given-names>TT</given-names></name> <name><surname>Stevens</surname> <given-names>MB</given-names></name> <name><surname>Alexander</surname> <given-names>GE</given-names></name></person-group> <article-title>Neurologic complications of primary Sj&#x00F6;gren&#x0027;s syndrome</article-title> <source>Medicine (Baltimore)</source> <year>1982</year> <volume>61</volume> <fpage>247</fpage><lpage>57</lpage></element-citation></ref>
<ref id="b2-jrd-20-319"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandler</surname> <given-names>RN</given-names></name></person-group> <article-title>Neuromyelitis optica - Devic&#x0027;s syndrome, update</article-title> <source>Autoimmun Rev</source> <year>2006</year> <volume>5</volume> <fpage>537</fpage><lpage>43</lpage></element-citation></ref>
<ref id="b3-jrd-20-319"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minagar</surname> <given-names>A</given-names></name> <name><surname>Alexander</surname> <given-names>JS</given-names></name> <name><surname>Fowler</surname> <given-names>MR</given-names></name> <name><surname>Long</surname> <given-names>AC</given-names></name> <name><surname>Kelley</surname> <given-names>RE</given-names></name></person-group> <article-title>Devic disease: clinical course, pathophysiology, and management</article-title> <source>Pathophysiology</source> <year>2002</year> <volume>9</volume> <fpage>33</fpage></element-citation></ref>
<ref id="b4-jrd-20-319"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucchinetti</surname> <given-names>CF</given-names></name> <name><surname>Mandler</surname> <given-names>RN</given-names></name> <name><surname>McGavern</surname> <given-names>D</given-names></name> <name><surname>Bruck</surname> <given-names>W</given-names></name> <name><surname>Gleich</surname> <given-names>G</given-names></name> <name><surname>Ransohoff</surname> <given-names>RM</given-names></name> <etal/></person-group> <article-title>A role for humoral mechanisms in the pathogenesis of Devic&#x0027;s neuromyelitis optica</article-title> <source>Brain</source> <year>2002</year> <volume>125</volume> <fpage>1450</fpage><lpage>61</lpage></element-citation></ref>
<ref id="b5-jrd-20-319"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname> <given-names>CS</given-names></name> <name><surname>Butler</surname> <given-names>E</given-names></name> <name><surname>Rom&#x00E1;n</surname> <given-names>GC</given-names></name></person-group> <article-title>Treatment of myel-opathy in Sj&#x00F6;gren syndrome with a combination of prednisone and cyclophosphamide</article-title> <source>Arch Neurol</source> <year>2001</year> <volume>58</volume> <fpage>815</fpage><lpage>9</lpage></element-citation></ref>
<ref id="b6-jrd-20-319"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wingerchuk</surname> <given-names>DM</given-names></name> <name><surname>Lennon</surname> <given-names>VA</given-names></name> <name><surname>Lucchinetti</surname> <given-names>CF</given-names></name> <name><surname>Pittock</surname> <given-names>SJ</given-names></name> <name><surname>Weinshenker</surname> <given-names>BG</given-names></name></person-group> <article-title>The spectrum of neuromyelitis optica</article-title> <source>Lancet Neurol</source> <year>2007</year> <volume>6</volume> <fpage>805</fpage><lpage>15</lpage></element-citation></ref>
<ref id="b7-jrd-20-319"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Protti</surname> <given-names>A</given-names></name> <name><surname>Erminio</surname> <given-names>C</given-names></name> <name><surname>Piccolo</surname> <given-names>I</given-names></name> <name><surname>Spreafico</surname> <given-names>C</given-names></name> <name><surname>Colombo</surname> <given-names>F</given-names></name> <name><surname>Ghezzi</surname> <given-names>A</given-names></name></person-group> <article-title>An unusual case with relapsing neuromyelitis optica associated with undifferentiated connective tissue disease</article-title> <source>Neurol Sci</source> <year>2004</year> <volume>25</volume> <issue>Suppl 4</issue> <fpage>S383</fpage><lpage>5</lpage></element-citation></ref>
<ref id="b8-jrd-20-319"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lennon</surname> <given-names>VA</given-names></name> <name><surname>Wingerchuk</surname> <given-names>DM</given-names></name> <name><surname>Kryzer</surname> <given-names>TJ</given-names></name> <name><surname>Pittock</surname> <given-names>SJ</given-names></name> <name><surname>Lucchinetti</surname> <given-names>CF</given-names></name> <name><surname>Fujihara</surname> <given-names>K</given-names></name> <etal/></person-group> <article-title>A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis</article-title> <source>Lancet</source> <year>2004</year> <volume>364</volume> <fpage>2106</fpage><lpage>12</lpage></element-citation></ref>
<ref id="b9-jrd-20-319"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wingerchuk</surname> <given-names>DM</given-names></name> <name><surname>Lennon</surname> <given-names>VA</given-names></name> <name><surname>Pittock</surname> <given-names>SJ</given-names></name> <name><surname>Lucchinetti</surname> <given-names>CF</given-names></name> <name><surname>Weinshenker</surname> <given-names>BG</given-names></name></person-group> <article-title>Revised diagnostic criteria for neuromyelitis optica</article-title> <source>Neurology</source> <year>2006</year> <volume>66</volume> <fpage>1485</fpage><lpage>9</lpage></element-citation></ref>
<ref id="b10-jrd-20-319"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname> <given-names>YS</given-names></name> <name><surname>Yoo</surname> <given-names>JK</given-names></name> <name><surname>Kwon</surname> <given-names>DY</given-names></name> <name><surname>Park</surname> <given-names>MH</given-names></name> <name><surname>Koh</surname> <given-names>SB</given-names></name> <name><surname>Kim</surname> <given-names>BJ</given-names></name> <etal/></person-group> <article-title>Neuromyelitis optica with positive anti-Ro and anti-La antibodies</article-title> <source>J Korean Neurol Assoc</source> <year>2009</year> <volume>27</volume> <fpage>446</fpage><lpage>8</lpage></element-citation></ref>
<ref id="b11-jrd-20-319"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keegan</surname> <given-names>M</given-names></name> <name><surname>Pineda</surname> <given-names>AA</given-names></name> <name><surname>McClelland</surname> <given-names>RL</given-names></name> <name><surname>Darby</surname> <given-names>CH</given-names></name> <name><surname>Rodriguez</surname> <given-names>M</given-names></name> <name><surname>Weinshenker</surname> <given-names>BG</given-names></name></person-group> <article-title>Plasma exchange for severe attacks of CNS demyelination: predictors of response</article-title> <source>Neurology</source> <year>2002</year> <volume>58</volume> <fpage>143</fpage><lpage>6</lpage></element-citation></ref>
<ref id="b12-jrd-20-319"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandler</surname> <given-names>RN</given-names></name> <name><surname>Ahmed</surname> <given-names>W</given-names></name> <name><surname>Dencoff</surname> <given-names>JE</given-names></name></person-group> <article-title>Devic&#x0027;s neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine</article-title> <source>Neurology</source> <year>1998</year> <volume>51</volume> <fpage>1219</fpage><lpage>20</lpage></element-citation></ref>
<ref id="b13-jrd-20-319"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname> <given-names>A</given-names></name> <name><surname>Weinshenker</surname> <given-names>BG</given-names></name> <name><surname>Violich</surname> <given-names>I</given-names></name> <name><surname>McLinskey</surname> <given-names>N</given-names></name> <name><surname>Krupp</surname> <given-names>L</given-names></name> <name><surname>Fox</surname> <given-names>RJ</given-names></name> <etal/></person-group> <article-title>Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients</article-title> <source>Arch Neurol</source> <year>2008</year> <volume>65</volume> <fpage>1443</fpage><lpage>8</lpage></element-citation></ref>
<ref id="b14-jrd-20-319"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname> <given-names>T</given-names></name> <name><surname>Fujihara</surname> <given-names>K</given-names></name> <name><surname>Nakashima</surname> <given-names>I</given-names></name> <name><surname>Misu</surname> <given-names>T</given-names></name> <name><surname>Miyazawa</surname> <given-names>I</given-names></name> <name><surname>Nakamura</surname> <given-names>M</given-names></name> <etal/></person-group> <article-title>Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre</article-title> <source>Brain</source> <year>2007</year> <volume>130</volume> <fpage>1235</fpage><lpage>43</lpage></element-citation></ref>
<ref id="b15-jrd-20-319"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnan</surname> <given-names>M</given-names></name> <name><surname>Cabre</surname> <given-names>P</given-names></name></person-group> <article-title>Plasma exchange in severe attacks of neuromyelitis optica</article-title> <source>Mult Scler Int</source> <year>2012</year> <year>2012</year> <fpage>787630</fpage></element-citation></ref>
</ref-list>
<sec sec-type="display-objects">
<title>Figures</title>
<fig id="F1-jrd-20-319" position="anchor">
<label>Figure 1.</label>
<caption xml:lang="en"><p>In T2 weighted magnetic resonance imaging, sagittal view shows extensive longitudinal high signal intensity lesion from cervical (C2) to upper thoracic (T4) spinal cord (A). Also transverse view show high signal intensity with cord swelling in C5 level (B) (whtie arrow).</p></caption>
<graphic xlink:href="jrd-20-319f1.tif"/>
</fig>
<fig id="F2-jrd-20-319" position="anchor">
<label>Figure 2.</label>
<caption xml:lang="en"><p>In T2 weighted magnetic resonance imaging, sagittal (A) and transverse (B) view shows decreased high signal intensity lesion, compared to prior test (C3-T3), after 1 month later (whtie arrow).</p></caption>
<graphic xlink:href="jrd-20-319f2.tif"/>
</fig>
</sec>
</back>
</article>